JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue65,20171,64437,197-
Cost of Revenue30,88829,98315,6406,360
Gross Profit34,31341,66121,557-6,360
Operating Expenses
Research Development33,43831,68819,26415,770
Selling General and Administrative32,16929,18816,7598,266
Non Recurring----
Total Operating Expenses96,49590,85951,66330,396
Operating Income or Loss-31,294-19,215-14,466-30,396
Income from Continuing Operations
Total Other Income/Expenses Net3,9612,8087631,864
Earnings Before Interest and Taxes-31,294-19,215-14,466-30,396
Interest Expense----
Income Before Tax-27,333-16,407-13,703-28,532
Income Tax Expense4636--
Minority Interest----
Net Income From Continuing Ops-27,379-16,443-13,703-28,532
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-27,379-16,443-13,703-28,532
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-27,379-17,237-23,138-37,503